Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Dec 3:26:e53834.
doi: 10.2196/53834.

Patients' and Clinicians' Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative Study

Affiliations
Randomized Controlled Trial

Patients' and Clinicians' Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative Study

Lisa McCann et al. J Med Internet Res. .

Abstract

Background: Patients receiving chemotherapy require ongoing symptom monitoring and management to optimize their outcomes. In recent years, digital remote monitoring interventions have emerged to provide enhanced cancer care delivery experiences to patients and clinicians. However, patient and clinician experiential evaluations of these technologies are rare. Therefore, we explored user experiences and perceptions of one such intervention-Advanced Symptom Management System (ASyMS)-after its scaled deployment in the context of the Electronic Symptom Management System Remote Technology (eSMART) trial. The eSMART trial was a large, multicenter randomized controlled trial to evaluate the efficacy of ASyMS in 12 clinical sites in 5 European countries.

Objective: In this qualitative study, both patients' and clinicians' experiences of using ASyMS for up to 6 cycles of chemotherapy were explored to understand the impact of ASyMS on patients' experiences, clinical practice, and supportive care delivery.

Methods: For this analysis, individual, semistructured, one-to-one interviews with 29 patients with breast, colorectal, and hematological cancers and 18 clinicians from Austria, Greece, Ireland, Norway, and the United Kingdom were conducted. Interviews focused on patients' and clinicians' experiences of using ASyMS, care organization and changes in practice following the introduction of ASyMS, perceived changes in care associated with the use of ASyMS, and its potential for future integration into routine chemotherapy care pathways.

Results: Thematic analysis identified several themes that describe patients' and clinicians' experiences using ASyMS. One central orienting theme-ASyMS as a facilitator of change-was supported by 5 key themes associated with human and technology monitoring: reassurance, enhanced communications and relationships, knowing what is "normal" and what is to be expected, enhancing cancer care experiences, and informing future cancer care.

Conclusions: This study is the first to evaluate both patients' and clinicians' experiences of using a digital health intervention to remotely monitor chemotherapy symptoms across 5 countries. Experiences with ASyMS were positive from both patients' and clinicians' perspectives, although some improvements to support the wider-scale rollout and sustained implementation were identified. Overall, this study demonstrates that real-time remote monitoring systems can help patients feel more reassured during their chemotherapy treatments and can help clinicians provide the right care, at the right time, and in the right place.

Trial registration: ClinicalTrials.gov NCT02356081; https://clinicaltrials.gov/study/NCT02356081.

International registered report identifier (irrid): RR2-10.1136/bmjopen-2016-015016.

Keywords: cancer; clinician experiences; digital interventions; patient experiences; qualitative methods; remote monitoring.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: AF is the managing director of Docobo, the health technology software development company that built the advanced symptom management system platform for the electronic symptom management system remote technology study. Docobo was a named partner in the program of work and received funding (grant 602289) for this development work.

Figures

Figure 1
Figure 1
Central orienting theme and supporting themes identified from analysis of patient and clinician interviews. ASyMS: Advanced Symptom Management System.

References

    1. Brianna. Lee SH. Chemotherapy: how to reduce its adverse effects while maintaining the potency? Med Oncol. 2023;40(3):88. doi: 10.1007/s12032-023-01954-6.10.1007/s12032-023-01954-6 - DOI - PubMed
    1. Coolbrandt A, Wildiers H, Laenen A, Aertgeerts B, Dierckx de Casterlé B, van Achterberg T, Milisen K. A nursing intervention for reducing symptom burden during chemotherapy? Oncol Nurs Forum. 2018;45(1):115–128. doi: 10.1188/18.ONF.115-128. - DOI - PubMed
    1. McGregor BA, Vidal GA, Shah SA, Mitchell JD, Hendifar AE. Remote oncology care: review of current technology and future directions. Cureus. 2020;12(8):e10156. doi: 10.7759/cureus.10156. https://europepmc.org/abstract/MED/33014652 - DOI - PMC - PubMed
    1. Palos GR, Suarez-Almazor ME. Launching an electronic patient-reported outcomes initiative in real-time clinical practice. J Natl Cancer Inst Monogr. 2021;2021(57):23–30. doi: 10.1093/jncimonographs/lgab005.6363779 - DOI - PubMed
    1. Girgis A, Bamgboje-Ayodele A, Rincones O, Vinod SK, Avery S, Descallar J, Smith A', Arnold B, Arnold A, Bray V, Durcinoska I, Rankin NM, Delaney GP. Stepping into the real world: a mixed-methods evaluation of the implementation of electronic patient reported outcomes in routine lung cancer care. J Patient Rep Outcomes. 2022;6(1):70. doi: 10.1186/s41687-022-00475-6. https://doi.org/10.1186/s41687-022-00475-6 10.1186/s41687-022-00475-6 - DOI - DOI - PMC - PubMed

Publication types

Substances

Associated data